DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: ZYFLO CR

Summary for Tradename: ZYFLO CR

Patents:1
Applicants:1
NDAs:1
Suppliers: see list1
drug
patent expirations by year for
 ZYFLO CR

Pharmacology for Tradename: ZYFLO CR

Clinical Trials for: ZYFLO CR

Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia
Status: Recruiting Condition: Chronic Myelogenous Leukemia

Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
Status: Terminated Condition: Chronic Myelogenous Leukemia

Trial of Zileuton CR in Children and Adults With Sickle Cell Disease
Status: Active, not recruiting Condition: Sickle Cell Disease

Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients
Status: Completed Condition: Asthma

Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS
Status: Terminated Condition: Asthma

Zileuton and Exhaled Nitric Oxide in Asthmatics
Status: Completed Condition: Asthma

Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)
Status: Terminated Condition: Pulmonary Disease, Chronic Obstructive

Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
Status: Completed Condition: Idiopathic Pulmonary Fibrosis

Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
Status: Recruiting Condition: Lung Inflammation

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
Status: Completed Condition: Tobacco Use Disorder

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cornerstone Therap
ZYFLO CR
zileuton
TABLET, EXTENDED RELEASE;ORAL022052May 30, 2007RXYes6,183,778<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc